EV Biologics, Inc. (YECO)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0192 (23.76%)
At close: Oct 24, 2025
EV Biologics Market Cap
EV Biologics has a market cap or net worth of $1.02 million as of November 14, 2025. Its market cap has decreased by -92.47% in one year.
Market Cap
1.02M
Enterprise Value
n/a
Revenue
9.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since June 29, 2015, EV Biologics's market cap has decreased from 70.39M to 1.02M, a decrease of -98.55%. That is a compound annual growth rate of -33.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 1.02M | 4.71% |
| Dec 31, 2024 | 976.52K | -90.45% |
| Dec 20, 2023 | 10.23M | -56.18% |
| Dec 28, 2022 | 23.33M | 109.88% |
| Dec 31, 2021 | 11.12M | -83.80% |
| Dec 31, 2020 | 68.63M | 4,887.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 693.46M |
| Glass House Brands | 583.42M |
| American Oncology Network | 371.75M |
| Northwest Biotherapeutics | 367.30M |
| Silence Therapeutics | 317.41M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.39M |